TrialJournal of the American Heart Association2018

Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial.

Thor Ueland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.